Cresco Labs (CRLBF) Selling, General & Administrative (2020 - 2026)
Cresco Labs (CRLBF) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 317.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.80 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 206.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.13 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 439.70 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 449.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Cresco Labs | 292.94 Mn | 228.83 Mn | 86.95 Mn | 73.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.28 Mn |
| Dec 31, 2025 | 57.01 Mn |
| Sep 30, 2025 | 59.17 Mn |
| Jun 30, 2025 | 51.40 Mn |
| Mar 31, 2025 | 65.04 Mn |
| Dec 31, 2024 | 56.03 Mn |
| Sep 30, 2024 | 64.78 Mn |
| Jun 30, 2024 | 62.40 Mn |
| Mar 31, 2024 | 63.05 Mn |
| Dec 31, 2023 | 56.77 Mn |
| Sep 30, 2023 | 71.91 Mn |
| Jun 30, 2023 | 75.95 Mn |
| Mar 31, 2023 | 82.29 Mn |
| Dec 31, 2022 | 80.19 Mn |
| Sep 30, 2022 | 82.87 Mn |
| Jun 30, 2022 | 90.15 Mn |
| Mar 31, 2022 | 87.11 Mn |
| Dec 31, 2021 | 70.54 Mn |
| Sep 30, 2021 | 81.39 Mn |
| Jun 30, 2021 | 86.11 Mn |